Related Experiment Video
Updated: Aug 7, 2026
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Pathogenesis of intractable chronic lymphocytic leukemia (ICLL)
1Research Service, VA Hospital, Hines, IL 60126.
Medical Hypotheses
|December 1, 1989
Summary
Intractable chronic lymphocytic leukemia (CLL) patients exhibit radioresistant lymphocytes, suggesting a distinct disease. This radioresistance may offer a novel diagnostic approach for intractable CLL.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Approximately 23% of chronic lymphocytic leukemia (CLL) patients develop chemotherapy resistance, termed intractable CLL (ICLL).
- Splenectomy has shown potential therapeutic benefits for patients with ICLL.
- Peripheral blood lymphocytes from ICLL patients demonstrate radioresistance in vitro.
Purpose of the Study:
- To investigate the radioresistance of lymphocytes in intractable chronic lymphocytic leukemia (CLL).
- To explore the potential of lymphocyte radioresistance as a diagnostic marker for ICLL.
- To hypothesize the origins and distinct nature of ICLL.
Main Methods:
- In vitro assessment of peripheral blood lymphocyte radioresistance in ICLL patients.
- Comparison of radioresistance between ICLL lymphocytes and normal lymphocytes.
- Evaluation of the effect of mitogens on the radiosensitivity of normal lymphocytes.
Main Results:
- Peripheral blood lymphocytes from ICLL patients were found to be radioresistant in vitro.
- Normal lymphocytes are typically radiosensitive but become radioresistant when exposed to mitogens like phytohemagglutinin.
- This differential radioresistance suggests a potential diagnostic test for ICLL.
Conclusions:
- ICLL may originate from splenic lymphocytes that have undergone immune stimulation.
- The findings support the hypothesis that ICLL is a distinct disease with unique pathogenesis, diagnostic criteria, and therapeutic strategies.
- Lymphocyte radioresistance could serve as a diagnostic indicator for intractable chronic lymphocytic leukemia.
More Related Videos
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...